0001140361-24-023012.txt : 20240429 0001140361-24-023012.hdr.sgml : 20240429 20240429163059 ACCESSION NUMBER: 0001140361-24-023012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240426 FILED AS OF DATE: 20240429 DATE AS OF CHANGE: 20240429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gurrola Sandra M CENTRAL INDEX KEY: 0001618457 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 24891494 MAIL ADDRESS: STREET 1: 2231 RUTHERFORD ROAD STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eterna Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1035 CAMBRIDGE STREET STREET 2: SUITE 18A CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 10531 4S COMMONS DRIVE STREET 2: SUITE 166-550 CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml FORM 4 X0508 4 2024-04-26 0000748592 Eterna Therapeutics Inc. ERNA 0001618457 Gurrola Sandra M C/O ETERNA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, SUITE 18A CAMBRIDGE MA 02141 true Sr. VP of Finance false Stock Option (Right to buy) 1.74 2024-04-26 4 A 0 80000 0 A 2034-04-26 Common Stock 80000 80000 D The stock option shall vest in an initial installment of one-third on the one-year anniversary of the grant date, and the remaining shares shall vest in 24 substantially equal monthly installments thereafter. /s/ Sandra Gurrola 2024-04-29